About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalNJ, NY, PA
Team (15)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
378
By Phase
PHASE4: 2PHASE3: 2PHASE2: 2
By Status
COMPLETED: 4UNKNOWN: 2TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05070455Lead Sponsor
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
PHASE4Unknown
12 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2023
NCT03037359Lead Sponsor
A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
N/AUnknown
200 participants
Started: Dec 31, 2016 · Completed: Jun 30, 2023
NCT03164967Lead Sponsor
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
PHASE4Completed
16 participants
Started: Dec 29, 2016 · Completed: Dec 31, 2022
NCT01814800Lead Sponsor
Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)
PHASE3Completed
59 participants
Started: Feb 28, 2014 · Completed: Jan 31, 2015
NCT00632463Lead Sponsor
RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness
PHASE2Completed
21 participants
Started: Feb 29, 2008 · Completed: May 31, 2010
Locations (1)
Headquarters
Ramsey, NJ, United States
Map
Loading map...